Page last updated: 2024-08-21

alpha-aminopyridine and Peritoneal Neoplasms

alpha-aminopyridine has been researched along with Peritoneal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Cheng, MY; Gao, HF; Ji, F; Li, JQ; Niu, G; Wang, K; Yang, CQ; Yang, M; Zhang, JS; Zhang, LL; Zhang, QZ; Zhu, T1
Guarino, S; Massaioli, C; Stocchi, L1

Other Studies

2 other study(ies) available for alpha-aminopyridine and Peritoneal Neoplasms

ArticleYear
Peritoneal Metastasis After Treated With Abemaciclib Plus Fulvestrant for Metastatic Invasive Lobular Breast Cancer: A Case Report and Review of the Literature.
    Frontiers in endocrinology, 2021, Volume: 12

    Topics: Aminopyridines; Benzimidazoles; Breast Neoplasms; Fatal Outcome; Female; Fulvestrant; Humans; Middle Aged; Neoplasm Metastasis; Peritoneal Neoplasms

2021
Ribociclib therapy in peritoneal carcinomatosis secondary to HER2-negative metastatic breast cancer: A clinical case with a positive outcome.
    The breast journal, 2020, Volume: 26, Issue:9

    Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Peritoneal Neoplasms; Purines; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone

2020